Vascular Access Device 101 - INFUSION Article
-
Register
- Prices available after logging in
Vascular access devices (VADs), including PICCs, Hickman catheters, midlines, IJ catheters, and PIVs, are critical tools for intravenous (IV) therapy but are often surrounded by confusing terminology that can lead to errors in patient care. Understanding the proper use, placement, and indications for each type of VAD is essential, especially in home infusion settings where staff may not see the devices firsthand. IV therapy is often required when oral medications are ineffective or the gastrointestinal system is compromised, and the choice between peripheral and central access depends on the therapy’s characteristics, duration, and patient factors. Peripheral devices are preferred for short-term, less complex infusions, while central venous access devices (CVADs) are suited for longer-term, more intensive therapies. Clear, consistent terminology and adherence to evidence-based standards can improve patient safety, guide appropriate device selection, and support optimal health outcomes.
Learning Objectives:
- Verbalize the importance of the use of correct terminology in describing access devices.
- List the criteria for appropriate peripheral infusion administration.
- Identify the central vascular access devices appropriate for long-term therapy.
Barbara McElroy, MSN, CRNI, VA-BC
Consultant
Consultant
Barbara McElroy, MSN, CRNI®, VA-BC™ is a clinical educator with 3 decades of experience in infusion and oncology nursing. She is an active contributor, writer, and speaker for multiple professional organizations with expertise in standards of care, evidence-based practice, and quality improvement initiatives. Barbara is an experienced nursing faculty in both pre and post-license BSN programs; a director of an LPN IV certification program; and provides expertise in the standard of care in legal cases. Barbara divides her time between the NH White Mountains and the Texas Hill Country.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Barbara McElroy has no relevant financial relationships with ineligible companies to disclose.